Menu

Gene Drive Limitations

In lab populations of genetically engineered mosquitoes, mutations arose that blocked the gene drive’s spread and restored female fertility.

Oct 9, 2017
Jef Akst

Anopheles gambiae mosquitoFLICKR, NIAID Researchers have eyed gene drives—selfish genetic elements that promote their own inheritance and spread—for controlling populations of disease-carrying mosquitoes. But a new study published last week (October 4) in PLOS Genetics documents a major hurdle: preventing the insects’ evolution to resist the effects of the introduced genetic element. 

Tony Nolan of Imperial College London, U.K., and colleagues designed a gene drive that targeted genes involved in egg production to successfully reduce the number of offspring that female Anopheles gambiae mosquitoes produced. The drive included a CRISPR-Cas9–based system to copy the fertility-reducing elements onto homologous chromosomes, so that the gene drive was inherited by nearly all offspring, rather than just half—resulting in its spread through the entire captive population within just four generations. But the insects soon began to evolve mutations that restored fertility and blocked the continued spread of the gene drive.

“Reducing the numbers of mosquito vectors has been the most effective tool to date for the control of malaria, so self-sustaining gene drives designed with this purpose have great potential,” Nolan says in a press release. “However gene drives are not a silver bullet and just like antibiotics can select for resistance in bacteria, gene drives can be susceptible to resistance at their target site.”

See “Using Gene Drives to Limit the Spread of Malaria” (written by Nolan and colleague)

Without gene drive, an allele will be passed from generation to generation via traditional Mendelian genetics. That is, when a heterozygous individual carrying only one copy of the allele mates with an individual lacking it, only half of their offspring will inherit the genetic segment. But in a gene drive that spreads the allele to the homologous chromosome in the germline, all progeny will receive a copy.

 

See “Infographic: Using Gene Drive to Control Malaria

Documenting mutations that convey resistance to a gene drive, as this study does, could inform the future development of more-robust technologies, the researchers say. “Our findings allow us to improve predictions on gene drive behaviour and to make concrete recommendations on how to improve future gene drive designs by decreasing the likelihood that they generate resistance,” they write in their paper.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!